Many existing pharmacological treatments for behavioural aspects of common clinical disorders, such as antidepressant medications [47] and cholinesterase inhibitors for Alzheimers disease [48], have an effect size of around 0.3 or less. Here, BCHE is linked to early-onset autosomal dominant Alzheimer disease.